Four-month rifapentine regimen with moxifloxacin noninferior for TB
(HealthDay)—A four-month rifapentine-based regimen containing moxifloxacin is noninferior to a standard six-month regimen for treatment of tuberculosis, according to a study published in the May 6 issue of the New England ...
May 6, 2021
0
0